We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
-0.32%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$6.4B
AUM Growth
-$2.91B
Cap. Flow
-$2.77B
Cap. Flow %
-43.38%
Top 10 Hldgs %
64.6%
Holding
239
New
57
Increased
26
Reduced
57
Closed
84

Sector Composition

Rank Sector Weight
1 Healthcare 12.92%
2 Technology 7.16%
3 Industrials 2.45%
4 Consumer Discretionary 2.31%
5 Materials 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HHH icon
26
Howard Hughes
HHH
$3.92B
$45M 0.7%
364,003
+5,140
+1% +$636K
AGN
27
PUT
DELISTED
Allergan plc
AGN
$44.6M 0.7%
265,000
+245,000
+1,225% +$39.9M
S
28
PUT
DELISTED
Sprint Corporation
S
$43.5M 0.68%
7,055,000
+3,775,000
+115% +$26M
VSM
29
DELISTED
Versum Materials, Inc.
VSM
$43.1M 0.67%
815,000
+82,000
+11% +$4.26M
I
30
PUT
DELISTED
INTELSAT S. A.
I
$43M 0.67%
1,884,000
+1,272,500
+208% +$26.8M
PM icon
31
Philip Morris
PM
$294B
$41.8M 0.65%
+550,000
New +$43.6M
PCG icon
32
PUT
PG&E
PCG
$37.9B
$40.4M 0.63%
4,041,600
+3,721,600
+1,163% +$56.3M
GNW icon
33
Genworth Financial
GNW
$3.71B
$36.3M 0.57%
8,240,100
+8,230,100
+82,301% +$34.3M
ABBV icon
34
CALL
AbbVie
ABBV
$435B
$31.8M 0.5%
420,000
+250,000
+147% +$17.1M
GHDX
35
DELISTED
Genomic Health, Inc.
GHDX
$29.8M 0.47%
+440,000
New +$30.2M
VICI icon
36
VICI Properties
VICI
$29.1B
$29.4M 0.46%
1,300,000
-2,125,000
-62% -$46.4M
SYF icon
37
Synchrony
SYF
$25.8B
$28.4M 0.44%
832,401
-310,110
-27% -$10.6M
ET icon
38
Energy Transfer Partners
ET
$70B
$25.9M 0.4%
1,980,000
-65,000
-3% -$906K
RTX icon
39
RTX Corp
RTX
$300B
$24.2M 0.38%
281,253
-15,890
-5% -$1.32M
SPY icon
40
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$819B
$23.7M 0.37%
+80,000
New +$23.6M
PVTL
41
DELISTED
Pivotal Software, Inc.
PVTL
$23.3M 0.37%
+1,564,830
New +$19.1M
QQQ icon
42
PUT
Invesco QQQ Trust
QQQ
$480B
$23.1M 0.36%
122,200
-477,400
-80% -$90.5M
UNH icon
43
CALL
UnitedHealth
UNH
$375B
$20.1M 0.31%
92,500
+42,500
+85% +$10.3M
HUM icon
44
PUT
Humana
HUM
$43.7B
$19.9M 0.31%
+78,000
New +$21.9M
UNH icon
45
UnitedHealth
UNH
$375B
$19.6M 0.31%
90,000
-63,000
-41% -$15.2M
HHH icon
46
CALL
Howard Hughes
HHH
$3.92B
$17.5M 0.27%
141,615
+99,655
+238% +$12.3M
HUM icon
47
Humana
HUM
$43.7B
$16.9M 0.26%
66,000
+26,000
+65% +$7.29M
EXAS
48
PUT
DELISTED
Exact Sciences
EXAS
$16.3M 0.25%
+180,000
New +$20.5M
BITA
49
DELISTED
Bitauto Holdings Limited
BITA
$15.9M 0.25%
+1,062,385
New +$13M
UNH icon
50
PUT
UnitedHealth
UNH
$375B
$13.9M 0.22%
64,000
+54,000
+540% +$13M

Similar funds

Pentwater Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Pentwater Capital Management held 239 positions worth $6.4B, down 31% from $9.31B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Pentwater Capital Management withdrew a net $2.77B in Q3 2019, closing 84 positions and reducing 57 holdings. Its most notable exit was Anadarko Petroleum, an estimated $619M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.

Against the trend, Pentwater Capital Management opened a new position in Viacom Inc. Class B worth $48.1M.

  • Pentwater Capital Management's largest Q3 2019 buy was Viacom Inc. Class B: 2,000,100 shares worth $48.1M.
  • Pentwater Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $264M increase.
  • Pentwater Capital Management's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $582M.
  • Pentwater Capital Management fully exited Anadarko Petroleum in Q3 2019, selling an estimated $619M.
  • Pentwater Capital Management's ten largest holdings make up 65% of its $6.4B portfolio in Q3 2019.
  • Pentwater Capital Management opened 57 new positions and closed 84 in Q3 2019.
  • Pentwater Capital Management's portfolio value fell 31% quarter-over-quarter to $6.4B.

Based on Pentwater Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.